0.230
0.000 (0.00%)
Leap Market : Pharmaceuticals
| High | 0.000 |
| Low | 0.000 |
| Volume | - |
| Volume (B/S) | 35,500 / 1,500 |
| Price Bid/Ask | 0.150 / 0.230 |
| 52w | 0.160 - 0.280 |
| ROE | 4.55 |
| P/E | 78 |
| EPS | 0.30 |
| DPS | 0.20 |
| DY | 0.87% |
| NTA | 0.0660 |
| P/B | 3.48 |
| RPS | 7.07 |
| PSR | 3 |
| Market Cap | 34.3M |
| Shares (mil) | 149.01 |
| RSI(14) | Neutral 58.2 |
| Stochastic(14) | Neutral 50.0 |
| Average Volume | 0 |
| Relative Volume | 0.0 |
| EPS | DPS | NTA | Revenue | P/L | Quarter | Q Date | Financial Year | Announced | QoQ% | YoY% | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.000 | 0.0660 | 2.82m | 133.00k | 2 | 2020-12-31 | 31 Dec, 2020 | 2021-02-23 | 117% | 67.3% | View |
| -0.52 | 0.000 | 0.0650 | 1.41m | -782.00k | 1 | 2020-06-30 | 31 Dec, 2020 | 2020-08-07 | 295.5% | 213.3% | View |
| 0.27 | 0.200 | 0.0700 | 3.12m | 400.00k | 2 | 2019-12-31 | 31 Dec, 2019 | 2020-02-21 | 42% | 75.4% | View |
| 0.46 | 0.000 | 0.0700 | 3.17m | 690.00k | 1 | 2019-06-30 | 31 Dec, 2019 | 2019-08-07 | 57.5% | 27.8% | View |
| 1.11 | 0.610 | 0.0700 | 5.03m | 1.62m | 2 | 2018-12-31 | 31 Dec, 2018 | 2019-02-21 | 200.7% | 12% | View |
| 0.37 | 0.000 | 0.0600 | 2.87m | 540.00k | 1 | 2018-06-30 | 31 Dec, 2018 | 2018-08-07 | 62.8% | 55% | View |
| 0.21 | 0.230 | 0.0500 | 3.67m | 1.45m | 2 | 2017-12-31 | 31 Dec, 2017 | 2018-02-28 | 0% | 33.2% | View |
| Financial Year | Revenue ('000) | Net ('000) | EPS | Report |
|---|---|---|---|---|
| 31 Dec, 2020 | 4,235 | -649 | -0.43 | |
| 31 Dec, 2019 | 6,295 | 1,090 | 0.73 | |
| 31 Dec, 2018 | 7,898 | 2,164 | 1.48 | |
| 31 Dec, 2017 | 3,669 | 1,450 | 0.21 |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |
|---|---|---|---|---|---|---|---|
| 24 Dec 2019 | 31 Dec 2019 | First Interim Dividend | 02 Jan 2020 | 17 Jan 2020 | 0.0020 | Currency | View |
| 28 Jun 2019 | 31 Dec 2018 | Final Dividend | 15 Jul 2019 | 08 Aug 2019 | 0.0020 | Currency | View |
| 12 Dec 2018 | 31 Dec 2018 | First Interim Dividend | 26 Dec 2018 | 18 Jan 2019 | 0.0040 | Currency | View |
| Announced | EX Date | Subject | Ratio |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
CEO智胜未来
不谈恢弘而未能实现的2020国家宏愿，且看企业CEO务实到位的小步，如何实现国家、人民进步的一大步。Sinchew -
马矿业获1.3亿合约 替换国油气体管道
（吉隆坡7日讯）马矿业（MMCCORP，2194，主板交通与物流股）获国油气体（PETGAS，6033，主板公用事业股）颁发价值约1亿3140万令吉合约，为后者提供管道替换服务。马...Nanyang -
MMC联营公司获1.31亿输气管EPCC合约
TheEdge -
汇流方案势头强劲·明讯第三季净利3.58亿
明讯截至2019年9月30日第三季净利下滑30.21%至3亿5800万令吉，去年同期为5亿1300万令吉。Sinchew -
Finance: Not such a great LEAP forward
TheEdge
Recent Announcements
-
MATERIAL LITIGATION
NOVA PHARMA SOLUTIONS BERHAD ("NPS" OR "THE COMPANY") - Material Litigation Between NPS ("Plaintiff") vs Oriental Mace Sdn. Bhd. ("OMSB") (Defendant) -
OTHERS
NOVA PHARMA SOLUTIONS BERHAD (NPS OR THE COMPANY) - Postponement of the Forty-Third Annual General Meeting (43rd AGM) -
General Meetings: Notice of Meeting
-
MATERIAL LITIGATION
NOVA PHARMA SOLUTIONS BERHAD ("NPS" OR "THE COMPANY") - Material Litigation Between NPS (Plaintiff) vs Oriental Mace Sdn Bhd (Defendant) -
Annual Audited Accounts - 31 Dec 2020
More analytics: